首页> 外文期刊>The journal of clinical endocrinology and metabolism >Higher Adiponectin Levels in Patients with Berardinelli-Seip Congenital Lipodystrophy due to Seipin as compared with 1-Acylglycerol-3-Phosphate-O-Acyltransferase-2 Deficiency
【24h】

Higher Adiponectin Levels in Patients with Berardinelli-Seip Congenital Lipodystrophy due to Seipin as compared with 1-Acylglycerol-3-Phosphate-O-Acyltransferase-2 Deficiency

机译:与1-Acylglycerol-3-磷酸-O-Acyltransferase-2缺乏症相比,因Seipin引起的Berardinelli-Seip先天性脂肪营养不良患者的脂联素水平更高

获取原文
       

摘要

Context: Human lipodystrophies are characterized by loss of adipose tissue, insulin resistance, and metabolic complications. The mechanisms linking fat loss to severe insulin resistance remain unclear. Adipokines may have important roles as intermediary players in metabolism.Objective: We sought to determine the plasma concentrations of leptin and adiponectin in patients with Berardinelli-Seip congenital lipodystrophy (BSCL) harboring mutations in the genes encoding either 1-acylglycerol-3-phosphate- O -acyltransferase-2 (AGPAT2) or BSCL2/seipin, in comparison with patients with other forms of inherited or acquired lipodystrophies or insulin receptor alterations.Design: Leptin and total and high-molecular-weight adiponectin were measured in plasma of 16 BSCL1/AGPAT2 and 19 BSCL2/seipin patients and compared with heterozygous (n = 22) or nonmutated relatives (controls, n = 30); patients with Dunnigan-type partial lipodystrophy due to lamin A/C mutations (n = 23), HIV-related lipodystrophy (n = 124), and insulin receptor dysfunctions caused by mutations or autoantibodies (n = 17).Results: Leptin was dramatically decreased in BSCL patients as compared with other subgroups. Adiponectin was decreased in BSCL as compared with controls and patients with altered insulin receptor but was discrepant between the two BSCL subgroups. Whereas total and high-molecular-weight adiponectin levels were almost undetectable in BSCL1/AGPAT2 patients, higher levels were detected in BSCL2/seipin patients, comparable with those of patients with partial lipodystrophy. Adiponectin greater than 1.6 mg/liter had a 100% negative predictive value for AGPAT2 mutations in inherited lipodystrophies.Conclusions: The presence of circulating adiponectin in BSCL2/seipin patients with near absence of adipose tissue outlines the complexity of adiponectin biology. Use of circulating adiponectin might be helpful to guide the genetic investigations in BSCL.
机译:背景:人体脂肪营养不良的特征是脂肪组织减少,胰岛素抵抗和代谢并发症。脂肪减少与严重胰岛素抵抗相关的机制仍不清楚。目的:我们试图确定Berardinelli-Seip先天性脂肪营养不良(BSCL)患者中编码1-酰基甘油-3-磷酸酯-基因的突变的血浆中瘦素和脂联素的浓度。 O-酰基转移酶2(AGPAT2)或BSCL2 / seipin与其他形式的遗传性或获得性脂肪营养不良或胰岛素受体改变的患者相比设计:在16例BSCL1 /血浆中测定了瘦素以及总脂蛋白和高分子量脂联素AGPAT2和19例BSCL2 / seipin患者,并与杂合子(n = 22)或未突变的亲戚(对照组,n = 30)进行比较;因Lamin A / C突变引起的Dunnigan型局部脂肪营养不良(n = 23),与HIV相关的脂肪营养不良(n = 124)和由突变或自身抗体引起的胰岛素受体功能异常(n = 17)的患者。结果:瘦素显着与其他亚组相比,BSCL患者的病情下降。与对照组和胰岛素受体改变的患者相比,BSCL中的脂联素降低了,但在两个BSCL亚组之间却没有差异。在BSCL1 / AGPAT2患者中几乎检测不到总脂联素和高分子量脂联素水平,而在BSCL2 / seipin患者中检出的脂联素水平较高,与部分脂肪营养不良的患者相当。大于1.6 mg / L的脂联素对遗传性脂肪营养不良者的AGPAT2突变具有100%的阴性预测值。结论:BSCL2 / seipin患者中几乎没有脂肪组织的循环脂联素的存在概述了脂联素生物学的复杂性。循环脂联素的使用可能有助于指导BSCL的基因研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号